Eric J. Topol

TL;DR: The arguments in favor of the scorecard approach from the clinical medicine viewpoint are that the process of measuring outcome provides a formal approach to improving individual decision making and system-wide allocation of resources, as shown in other complex work environments with the adoption of the Deming method of continuous quality improvement.

TL;DR: Results suggest that adjunctive therapy with abciximab during percutaneous treatment of narrowed saphenous vein grafts reduces the occurrence of distal embolization, and possibly non-Q-wave AMI.

TL;DR: More efforts are needed both in terms of local drug elution as well as systemic pharmacologic therapies to further contain the excessive neointimal proliferation that characterizes the diabetic response to vascular injury.

TL;DR: In patients with multivessel CAD presenting with NSTE-ACS,Multivessel intervention was significantly associated with a lower revascularization rate, which translated to a lower incidence of the composite end point compared with culprit-only stenting.

TL;DR: These complications identified patients at greater risk of death, myocardial infarction or repeat revascularization at 30 days and 1 year and highlighted the need to prevent these periprocedural events and monitor patients closely.